[1]
Nayak, S. et al. 2024. Irisin levels in type 2 diabetes mellitus with and without non-alcoholic fatty liver disease: a case-control study. Prospects in Pharmaceutical Sciences. 22, 3 (Sep. 2024), 210–218. DOI:https://doi.org/10.56782/pps.254.